BTMD
biote Corp.Company Information
- Company Name
- biote Corp.
- CIK
- CIK0001819253
- Category
- Accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- BTMD: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2833
- SIC Description
- Medicinal Chemicals & Botanical Products
- Ticker
- BTMD
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-08-11
- Last sale
- 2024-09-09
- Shares purchased (TTM)
- 16,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 12,543,355
- Shares outstanding
- 28,626,136
- Ownership
- 43.82%
Earnings Market Reaction
- Filing date
- 2026-08-07
- Price on filing date
- —
- 1-month reaction
- 6.08%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Class A | 0 | 0 | 0 | -1 | 0 | 31 | 0 | 0 | -3 | 34 | 20 | 6 | ||||||
| Common Class V | 0 | 5 | 0 | 0 | 0 | 5 | 0 | 0 | -24 | 29 | 29 | -6 | ||||||
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 11 | 5 | 24 | 28 | 20 | 42 | 39 | 38 | 26 | 79 | 89 | 66 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 43 | 36 | 55 | 57 | 50 | 69 | 68 | 70 | 62 | 114 | 122 | 118 | ||||||
| Short Term Investments | - | - | - | - | - | - | - | - | - | - | - | 20 | ||||||
| Accounts Receivable Net Current | 8 | 7 | 7 | 8 | 9 | 8 | 8 | 8 | 8 | 8 | 7 | 10 | ||||||
| Inventory Net | 18 | 20 | 19 | 16 | 12 | 13 | 15 | 16 | 19 | 19 | 17 | 11 | ||||||
| Prepaid Expense And Other Assets Current | 6 | 4 | 5 | 5 | 9 | 6 | 6 | 7 | 8 | 9 | 9 | 11 | ||||||
| Property Plant And Equipment Net | 13 | 11 | 11 | 10 | 10 | 8 | 7 | 6 | 5 | 2 | 1 | 1 | ||||||
| Capitalized Computer Software Net | 5 | 5 | 5 | 3 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | ||||||
| Goodwill | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | - | - | ||||||
| Intangible Assets Net Excluding Goodwill | 4 | 4 | 4 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | - | - | ||||||
| Finite Lived Intangible Assets Net | 4 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 7 | 3 | 3 | 3 | 3 | 3 | 3 | 1 | 2 | 2 | 2 | 2 | ||||||
| Deferred Income Tax Assets Net | 25 | 24 | 25 | 27 | 28 | 28 | 29 | 6 | 8 | 25 | 25 | 23 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Assets | 102 | 89 | 108 | 111 | 105 | 123 | 122 | 101 | 93 | 160 | 155 | 150 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 7 | 8 | 7 | 4 | 4 | 3 | 6 | 4 | 6 | 4 | 4 | 6 | ||||||
| Accrued Liabilities Current | 14 | 10 | 10 | 11 | 9 | 10 | 11 | 8 | 7 | 10 | 8 | 10 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 30 | 28 | 45 | 56 | 51 | 48 | 52 | 47 | 46 | 24 | 22 | 25 | ||||||
| Long Term Debt Current | 3 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | ||||||
| Contract With Customer Liability Current | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Derivative Liabilities Current | 3 | - | - | - | - | - | 0 | 0 | 0 | 1 | - | - | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | ||||||
| Long Term Debt Noncurrent | 118 | 94 | 96 | 97 | 98 | 100 | 101 | 103 | 104 | 105 | 107 | 108 | ||||||
| Long Term Line Of Credit | 0 | 5 | 5 | - | - | - | - | - | - | - | - | - | ||||||
| Contract With Customer Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | ||||||
| Operating Lease Liability Noncurrent | 6 | 2 | 2 | 2 | 3 | 3 | 3 | 1 | 2 | 2 | 2 | 2 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | - | - | 2 | - | - | - | - | - | ||||||
| Derivative Liabilities Noncurrent | 0 | 2 | 4 | 5 | 8 | 6 | 17 | 16 | 24 | 53 | 41 | 46 | ||||||
| Liabilities | 160 | 137 | 158 | 177 | 184 | 208 | 225 | 228 | 235 | 205 | 192 | 201 | ||||||
| Additional Paid In Capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Retained Earnings Accumulated Deficit | -51 | -46 | -50 | -64 | -79 | -84 | -100 | -125 | -138 | -32 | -29 | -41 | ||||||
| Stockholders Equity | -66 | -48 | -59 | -73 | -85 | -85 | -102 | -127 | -141 | -36 | -37 | -51 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Treasury Stock Value | -15 | -10 | -9 | -9 | -6 | -6 | -6 | -6 | -6 | -4 | - | - | ||||||
| Minority Interest | 8 | 8 | 8 | 7 | 6 | 5 | 4 | 4 | 2 | -9 | -7 | -11 | ||||||
| Liabilities And Stockholders Equity | 102 | 89 | 108 | 111 | 105 | 123 | 122 | 101 | 93 | 160 | 155 | 150 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialbiote Corp. (BTMD) — SEC Financial Statements & Analysis
biote Corp. (BTMD) is a medicinal chemicals & botanical products company. biote Corp. trades on Nasdaq as: BTMD. biote Corp. (BTMD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07. Based on that filing, biote Corp. carries a market cap of $54.10M, a P/E ratio of 13.09x, a P/B ratio of -0.93x, a P/S ratio of 0.29x, an enterprise value of $164.44M, and an EV/EBITDA multiple of 8.84x. On profitability, it posts a gross margin of 68.58%, an operating margin of 8.04%, a net margin of 2.25%, a Return on Equity (ROE) of -6.03%, a Return on Assets (ROA) of 4.00%, and a Return on Invested Capital (ROIC) of 30.81%. Per share, it reports EPS of $0.14, diluted EPS of $0.14, free cash flow per share of $0.69, and a dividend per share of $0.04. Over the trailing year, it posted revenue growth of -7.81% year-over-year, net income growth of -87.03% year-over-year, and EPS growth of -85.68% year-over-year. On the balance sheet, it maintains a current ratio of 1.43x, a quick ratio of 0.63x, working capital of $12.94M, a debt-to-equity ratio of -2.75x, a debt ratio of 1.57, an interest coverage ratio of 1.58x, free cash flow of $19.87M (TTM), and net debt of $110.33M. Figures sourced from SEC EDGAR.
- Market Cap
- $54.10M
- P/E TTM
- 13.09x
- EPS TTM
- $0.14
- P/B TTM
- -0.93x
- ROE TTM
- -6.03%
- ROA TTM
- 4.00%
- Debt To Equity
- -2.75x
- Free Cash Flow TTM
- $19.87M
- Net Revenue TTM Growth 1Y
- -7.81%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is biote Corp. in?
biote Corp. (BTMD) operates in the Medicinal Chemicals & Botanical Products industry.
What exchange does BTMD trade on?
biote Corp. (BTMD) trades on the Nasdaq.
When was biote Corp. (BTMD)'s most recent SEC filing?
biote Corp. (BTMD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07.
What is BTMD's market cap?
biote Corp. (BTMD) has a market capitalization of $54.10M as of 2026-06-30.
What is BTMD's P/E ratio?
biote Corp. (BTMD)'s trailing twelve month P/E ratio is 13.09x as of 2026-06-30.
What is BTMD's EPS (earnings per share)?
biote Corp. (BTMD)'s trailing twelve month EPS is $0.14 as of 2026-06-30.
What is BTMD's ROE (return on equity)?
biote Corp. (BTMD)'s trailing twelve month Return on Equity (ROE) is -6.03% as of 2026-06-30.
What is BTMD's ROA (return on assets)?
biote Corp. (BTMD)'s trailing twelve month Return on Assets (ROA) is 4.00% as of 2026-06-30.
What is BTMD's ROIC (return on invested capital)?
biote Corp. (BTMD)'s trailing twelve month Return on Invested Capital (ROIC) is 30.81% as of 2026-06-30.
What is BTMD's EV/EBITDA?
biote Corp. (BTMD)'s trailing twelve month EV/EBITDA is 8.84x as of 2026-06-30.